We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approval Process Flawed From the Start, Avorn Says
FDA Approval Process Flawed From the Start, Avorn Says
August 29, 2007
The FDA should be able to give drugs provisional approval to ensure better tracking of safety and efficacy data, Harvard Medical School Professor Jerry Avorn said.